Gene: SNTB1
Official Full Name: syntrophin beta 1provided by HGNC
Gene Summary: Dystrophin is a large, rod-like cytoskeletal protein found at the inner surface of muscle fibers. Dystrophin is missing in Duchenne Muscular Dystrophy patients and is present in reduced amounts in Becker Muscular Dystrophy patients. The protein encoded by this gene is a peripheral membrane protein found associated with dystrophin and dystrophin-related proteins. This gene is a member of the syntrophin gene family, which contains at least two other structurally-related genes. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35321 | SNTB1 Knockout cell line (HeLa) | Human | SNTB1 | 1:3~1:6 | Negative | Online Inquiry |
KO35322 | SNTB1 Knockout cell line (HCT 116) | Human | SNTB1 | 1:2~1:4 | Negative | Online Inquiry |
KO35323 | SNTB1 Knockout cell line (HEK293) | Human | SNTB1 | 1:3~1:6 | Negative | Online Inquiry |
SNTB1 Gene Knockout Cell Lines are specially designed cellular models where the SNTB1 gene has been inactivated or "knocked out," enabling researchers to study the gene's function and its role in various biological processes. These cell lines serve as crucial tools in dissecting the molecular mechanisms underlying cell signaling, adhesion, and cytoskeletal dynamics that are modulated by SNTB1, also known as synaptic nerve terminal protein 1.
The key functions of SNTB1 include modulation of synaptic transmission and play a critical role in neuronal and muscle cell functioning. By utilizing SNTB1 knockout cell lines, scientists can explore how the absence of this protein affects cellular behavior, including proliferation, differentiation, and response to external stimuli. This provides insights into potential pathological conditions such as neurological disorders where SNTB1 may play a contributing role.
The scientific importance of SNTB1 Gene Knockout Cell Lines cannot be overstated, as they represent indispensable tools in both research and clinical settings. They facilitate drug discovery, the development of targeted therapies, and the investigation of gene functions in diseases. Researchers can use these models to evaluate the efficacy and safety of new therapeutic compounds aimed at modulating SNTB1-related pathways.
Unique advantages of our SNTB1 Gene Knockout Cell Lines include their high reproducibility and ease of use, supported by rigorous quality control measures during their development. Compared to traditional techniques such as RNA interference, gene knockout provides a more definitive and stable approach to gene function studies, allowing for long-term observation of cellular behaviors influenced by SNTB1.
Investing in SNTB1 Gene Knockout Cell Lines is advantageous for researchers and clinicians aiming to deepen their understanding of synaptic processes and harness this knowledge into practical applications for therapeutics. Our company prides itself on its commitment to high-quality biological products and a track record of excellence in delivering innovative research tools that empower the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.